Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Arcus ASA: Annual General Meeting 2020 is postponed

Arcus postpones its Annual General Meeting convened for 21 April 2020 to a later date.Based on the 2019 results, the Board of Directors had proposed a dividend in line with last year’s. In light of current uncertainty in society, due to the coronavirus outbreak, the Board of Directors believes the responsible action is to await further developments before making a dividend proposal and arranging the Annual General Meeting. Therefore, today the Board of Directors has decided to cancel the Annual General Meeting convened for 21 April 2020. The Board of Directors will convene the Annual

Finnair strengthens its funding position. The Ministerial Committee on Economic Policy has proposed that the State of Finland guarantees the pension premium loan included in the plan

Finnair Plc                  Stock Exchange Release                 20 March 2020 at 9.05 a.m. EET  Finnair announced in its Stock Exchange Release on 16 March 2020 that it is implementing a substantial funding plan in order to secure the company’s future even in a prolonged coronavirus situation. The plan includes funding instruments such as available credit lines, sale and leasebacks of unencumbered aircraft and a substantial, market-based pension premium loan. The available credit lines included in the funding plan consist of a revolving credit facility totaling to 175 million

Director/PDMR Shareholding

20 March 2020 07:00 GMT   Transaction by Person Discharging Managerial Responsibilities Disclosure under Article 19 of the EU Market Abuse Regulation   AstraZeneca PLC (the Company) announced that, on 19 March 2020, it was notified by Tony Mok, a Non-Executive Director of the Company, that, on 18 March 2020, Mr Mok purchased 1,000 of the Company's American Depositary Shares (ADSs) at a price of $38.32 per ADS. Two ADSs are equivalent to one Ordinary Share of $0.25 in the Company.   The attached notification, made in accordance with the requirements of the EU Market

Annual General Meeting in AQ Group AB (publ) on April 22, 2020

The Annual General Meeting in AQ Group AB (publ) will be held on Wednesday, April 22, 2020 at 18:00 at Aros Congress Center, Hörsalen plan 1, Västerås, Sweden.   Notice of the Annual General Meeting, with proposed agenda is included in its entirety in this press release and is published on the company web page www.aqg.se . The notice of the meeting is published in "Post- och Inrikes Tidningar" and an announcement with information that the notice has been issued is published in Dagens

Ole Kristian Jødahl appointed President and CEO of Alimak Group, effective as of June 1, 2020

The Board of Directors of Alimak Group has appointed Ole Kristian Jødahl as President and CEO of Alimak Group, effective as of June 1, 2020. Ole Kristian Jødahl is to succeed Tormod Gunleiksrud, who will, as previously communicated, leave the company after 8 years as President and CEO.   Ole Kristian Jødahl will join Alimak Group from the assignment as CEO of Hultafors Group. He has previously worked with operations management and held operational positions within SKF Group, most recently as Director, Sales & Marketing, Industrial Market, SKF Group. Ole Kristian Jødahl is a Norwegian

Procedures at Fabege’s Annual General Meeting on 2 April 2020

Due to the risk of contagion from Convid-19, Fabege will have special procedures in place at the Annual General Meeting on 2 April 2020.These procedures include the following: · Shareholders (private individuals, not legal entities) are being offered representation at the Annual General Meeting by proxy through, an employee of Euroclear Sweden AB. · In light of the authorities’ regulations, we would urge all shareholders to carefully consider using this opportunity to provide a power of attorney and voting instructions to a specially designated representative of Euroclear instead of

Atrium Ljungberg borrows SEK 920 million from Nordic Investment Bank

Atrium Ljungberg has signed a green bank loan from Nordic Investment Bank for SEK 920 million. The loan is unsecured and the time to maturity is seven years. The funds will be used in the development of the Life City project in Hagastaden, Stockholm.Atrium Ljungberg is a long-term property owner with a strong financial position. Its loan portfolio amounts to approximately SEK 20 billion, half of which is financed through the capital markets. The remainder consists of bank financing and direct lending. The unsecured bank loan of SEK 920 million is Atrium Ljungberg's first with Nordic

CONTINUED GROWTH AND INCREASED FOCUS ON PROFITABILITY

This is a translation of the Swedish interim report. If there should be any discrepancies, the Swedish language version governs.   FOURTH QUARTER, OCTOBER – DECEMBER 2019 · Net sales increased by 12.0%, or 10.7% FX adjusted, to MSEK 70.5 (63.0) · Gross profit increased by 7.7%, or 6.1% FX adjusted, to MSEK 54.0 (50.2) · EBIT was MSEK -5.3 (-3.6) · Earnings after tax was MSEK -6.2 (-2.9) · Earnings per share was, basic SEK -0.79 (-0.40), diluted SEK -0.79 (-0.40)   FULL YEAR, JANUARY – DECEMBER 2019 · Net sales increased by 8.9%, or 7.5% FX adjusted, to MSEK

Final Results for the year ended December 31, 2019

Faron Pharmaceuticals Oy ("Faron" or the "Company")   Financial statement release January 1 to December 31, 2019   Financial statement release, Turku, 20 March 2019 at 9.00 AM (EET) Inside information   TURKU, FINLAND - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today reports its financial statements for the year ended 31 December 2019 and H2 2019.   HIGHLIGHTS   Operational (including post period):   Clevegen[®] - Regulator of major inhibitory immune checkpoints and wholly-owned novel

Limitations to production in Antwerp, Belgium

Stockholm, Sweden, March 20, 2020: Due to new regulations from the Belgian government Atlas Copco’s production in Antwerp, Belgium is affected. A large part of the final assembly is temporarily stopped, while the compressor element production and the distribution center continue to operate. In total 900 out of 1400 employees will be temporarily unemployed from March 23 until April 2.Airpower in Belgium is Atlas Copco’s largest production site and manufactures mostly industrial and portable compressors.     At least 50% of the workforce in the distribution center and the compressor

Castellum stands on stable ground

Due to the prevailing situation on the stock market, Castellum has been flooded with questions from investors and market players which we unfortunately, owing to volatile circumstances, do not have the possibility to answer in full. We would therefore like to transmit this comprehensive fact commentary out to the equities market.The stock market’s pricing of the Castellum share is currently SEK 151, indicating at this time of writing that Castellum is now valued at approx. 77% of its long-range Net Asset Value at last yearend and that the yield amounts to 4.3%, based on the 2019 dividend of

Notice of Annual General Meeting in Bravida Holding AB (publ)

The shareholders in Bravida Holding AB (publ), reg. no. 556891-5390, are summoned to the annual general meeting to be held on Friday 24 April 2020, at 1.00 pm at the company’s offices on Mikrofonvägen 28, Hägersten, Sweden. Registration starts at 12.30 pm.Due to the current pandemic (COVID-19), Bravida Holding AB (publ) has taken a number of precautionary measures ahead of the annual general meeting aimed at keeping the meeting short and efficient and reduce the risk of spreading the virus. No food or drinks will be served before or after the annual general meeting. Bravida Holding AB (publ)

Caverion to be responsible for technical maintenance services for buildings at Stora Enso's Mill in Varkaus, Finland

Caverion Corporation Investor news 20 March 2020 at 09:00 a.m. EETCaverion to be responsible for technical maintenance services for buildings at Stora Enso's Mill in Varkaus, Finland Caverion has signed an agreement with Stora Enso Oyj and Efora Oy on the provision of services for the buildings at Stora Enso’s Varkaus Mill. The service agreement involves a transfer of business whereby the persons working in these activities will be transferred from Stora Enso and Efora to Caverion Suomi Oy as so-called old employees.  Caverion is responsible for the technical maintenance

Vicore informs on clinical programs in relation to the current outbreak of COVID-19

Gothenburg, March 20, 2020 – Vicore Pharma informs on clinical programs in relation to the current outbreak of COVID-19.The on-going clinical study of Raynaud’s phenomenon in patients with systemic sclerosis, in which effects of C21 on blood flow are being studied, has recruited faster than planned. However the clinical trial work will now slow down by trial participants avoiding non-essential hospital visits. “Ensuring safety of trial participants is paramount and based on the performance so far I believe we will be able to swiftly catch up and still report the results by the end of the

New Stirling laboratory in Gothenburg

Swedish Stirling AB has built a new laboratory and test centre for Stirling engines in Gothenburg. The facility, which is now ready for commissioning, will greatly strengthen the company's research and development capacity. The inauguration and demonstration of the facility will be timed depending on the development of the Covid-19 outbreak.[CEO Gunnar Larsson and technician Filip Franzn in Swedish Stirlings new Stirling laboratory]   During the winter, Swedish clean tech company Swedish Stirling built a brand new laboratory and test centre for Stirling engines. The facility, located

Northmill Group AB (publ) repurchases additional Bonds

Northmill Group AB (publ) (“Northmill Group” or “the Company”) has repurchased additional bonds with a nominal value of SEK 85,000,000. The repurchases concern the Company’s senior unsecured bonds with a nominal outstanding amount of SEK 500,000,000 (ISIN:SE0011614973). The bonds have a floating rate corresponding to STIBOR 3m plus 8.0 percent and are due in September 2021. The average purchase price corresponds to 98.58 percent of the nominal value of the bonds.The purpose of the repurchase is to improve Northmill Group’s net interest income. The repurchases have been made possible by

Increase in the number of shares registered in the trade register

Relais Group Plc Company Release 20 March 2020 at 9.00 a.m. EETTotal of 606,250 share subscriptions based on the directed share issue approved by the Board of Directors of Relais Group Plc on 6 February 2020, have been entered into the trade register today. The subscription price for the shares was EUR 8.6091 per share. The directed issue is related to the acquisition of TD Tunga Delar Sverige AB announced on 6 February 2020. With the closing of the acquisition, Relais Group Plc paid SEK 55.0 million of the purchase price by issuing a total of 606,250 new Relais Group Plc's shares to be

Wulff adjusts its outlook for 2020

STOCK EXCHANGE RELEASE March 20, 2020 at 9:00 A.M.   Wulff adjusts its outlook 2020 due to corona virus COVID-19 and preparations arising from it. Based on the Group management’s outlook, it is likely that the comparable operating profit will decrease from year 2019, which was EUR 1.7 million. Earlier the company estimated in its financial statements release on February 17, 2020, that the comparable operating profit will grow from year 2019.   Wulff Group Plc CEO Elina Pienimäki: “Due to corona virus and uncertainties in the global economy we estimate that the comparable

SBB initiates a collaboration with Stockholms Stadsmission to help mitigate the consequences of the COVID-19 crisis

Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB") initiates a collaboration with the charity Stockholms Stadsmission to help mitigate the consequences of the COVID-19 crisis. SBB will finance the purchase of food from various restaurants in Stockholm, which will then be donated to Stockholms Stadsmission that helps people in need in our city. Stockholms Stadsmission is the initial beneficiary and the food will be delivered to their operations for the elderly in St Paul. Through this initiative, SBB helps to mitigate negative consequences for some of the groups affected by the COVID-19

Oncopeptides provides update regarding COVID-19 impact on the melflufen clinical program

STOCKHOLM — March 20, 2020 — Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today measures the company is taking in response to the global spread of the novel coronavirus (COVID-19) pandemic. Most importantly, the pivotal phase 2 HORIZON study will not be affected and FDA submission plans are on track for a filing late Q2. The phase 3 OCEAN study with 423 out of 450 planned patients enrolled will remain open for patient enrolment. Topline results are expected to be only slightly delayed. Recruitment for other ongoing clinical studies will be put on temporary pause for patient safety

Orkla ASA: The nomination committee’s recommendation to the General Meeting of Orkla ASA

The Nomination Committee of Orkla ASA has submitted its recommendation regarding the election of shareholder-elected members and a deputy member of the Board of Directors, election of the Chair of the Board of Directors, election of members and the Chair of the Nomination Committee and determination of fees.Please find the recommendation enclosed.  Orkla ASAOslo, 20 March 2020 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

ContextVision – Mandatory notification of trade – primary insider

STOCKHOLM – March 20, 2020 – Monsun AS, controlled by Magne Jordanger, member of the board of ContextVision, has on March 19, 2020 purchased 49 250 shares in ContextVision AB at an average price of NOK 67,27 per share. After the transaction, Monsun AS holds a total of 2 298 000 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or visit www.contextvision.com. ### About ContextVision ContextVision is a medical technology software company that specializes in image analysis and artificial intelligence. As the

Orkla ASA: Orkla’s Annual Report 2019

Orkla's Annual Report for 2019, which also comprises Orkla’s sustainability report, is published today.The Annual Report is only available online. A compressed pdf version of the report is attached. The report is also available on Orkla’s website. Orkla ASAOslo, 20 March 2020Ref.:Group Director Corporate Communications and Corporate Affairs Håkon MageliTel.: +47 928 45 828Email: hakon.mageli@orkla.no VP Investor RelationsElise HeidenreichTel.: +47 951 41 147Email: elise.andersen.heidenreich@orkla.no This information is subject to the disclosure requirements

Redeye: Smart Eye - All Hail the King of DMS

Redeye raises long-term estimates and valuation following breaking news about no less than four new contracts, the composition of which is extremely attractive, in our view. Read more and download the research update: https://bit.ly/2J5g5Bi Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/

There are no items matching the current filter
There are no more items matching the current filter
Back to top